SALARIUS PHARMACEUTICALS INC (SLRX) Stock Cash Flow
NASDAQ:SLRX - Nasdaq - US79400X4043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.57M | -5.58M | -12.54M | -31.61M | -12.77M | |||
| Depreciation Amortization | 4.40K | 4.40K | 10.10K | 6.70K | 19.20K | |||
| Change In Working Capital | 982.80K | 772.30K | -968.30K | 2.37M | 2.03M | |||
| Interest Paid | 10.70K | 10.60K | 14.80K | 0.00 | 1.50K | |||
| Other non cash items | 229.70K | 273.70K | 654.80K | 11.64M | 514.40K | |||
| OPERATING CASH FLOW | -4.35M | -4.53M | -12.85M | -17.60M | -10.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | 0.00 | -1.50M | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | -1.50M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -403.30K | -466.50K | -280.90K | 0.00 | -477.00K | |||
| Stock Issued/Repurchased | 2.18M | 1.53M | 6.92M | 1.99M | 28.77M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 1.78M | 1.06M | 6.64M | 1.99M | 28.30M | |||
| CHANGE IN CASH | -2.57M | -3.47M | -6.21M | -17.11M | 18.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.35M | -4.53M | -12.85M | -17.60M | -10.20M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -4.35M | -4.53M | -12.85M | -17.60M | -10.20M | |||
All data in USD